• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods. Evaluation of an Epitope-Blocking Enzyme-Linked Immunosorbent Assay for the Detection of Antibodies to Influenza A Virus in Domestic

Giuseppe

Emeritus
J Virol Methods. 2009 Jun 10. [Epub ahead of print]

Evaluation of an Epitope-Blocking Enzyme-Linked Immunosorbent Assay for the Detection of Antibodies to Influenza A Virus in Domestic and Wild Avian and Mammalian Species.

Sullivan HJ, Blitvich BJ, Vandalen K, Bentler KT, Franklin AB, Root JJ. - United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, Fort Collins, Colorado, 80521, USA.


An epitope-blocking enzyme-linked immunosorbent assay (bELISA) was developed for the detection of antibodies to influenza A virus in taxonomically diverse domestic and wild vertebrate species. In contrast to the bELISAs published previously that require reagent production, manipulation by the end-user, or have not been evaluated for use with both mammalian and avian species, this assay is performed using commercially available recombinant nucleoprotein antigen and corresponding nucleoprotein-specific monoclonal antibody and has been shown to work with multiple avian and mammalian species. The efficacy of the bELISA as a serum screening assay was compared to the agar gel immunodiffusion (AGID) assay using 251 serum samples obtained from experimentally-infected mallards(Anas platyrhynchos) and raccoons (Procyon lotor). The concordance between the AGID assay and bELISA was 94.1% (95% CI = 89.9, 98.3) for raccoons, and 71.2% (95% CI = 63.5, 78.9) for mallards and 82.8% (95% CI = 78.2, 87.3) overall. The bELISA was more sensitive than the AGID assay as demonstrated by the detection of antibodies to influenza A virus at earlier time points in experimental infection studies and at higher serial dilutions. The efficacy of the bELISA to monitor natural influenza A virus exposure was also compared to the AGID assay using an additional 745 serum samples from six avian species and six mammalian species. This bELISA provides a rapid, reliable, and inexpensive technique for large-scale surveillance of influenza A virus exposure in taxonomically diverse vertebrate species.

PMID: 19523985 [PubMed - as supplied by publisher]
-
------
 
Back
Top